Crescent Biopharma, Inc. share price logo

Crescent Biopharma, Inc.

NASDAQ: CBIO

Small Cap

$17.82

-0.63

(-3.44%)

Live

as on

Crescent Biopharma, Inc. Stock Performance

as on June 6, 2026 at 1:36 am IST

  • Day's Low

    Day's High

    $17.71
    $19.00
    downward going graph

    0.62%

    Downside

    6.62%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $8.72
    $27.41
    downward going graph

    51.07%

    Downside

    53.82%

    Upside

    downward going graph

Crescent Biopharma, Inc. share price movements today

Previous Close
$18.45
Open
$18.19
Volume
52.1K
Day's Low - High
$17.71 - $19.00
52 Week Low - High
$8.72 - $27.41

Crescent Biopharma, Inc. Historical Returns

1 Month Return
+ 2.05 %
3 Month Return
+ 62.84 %
1 Year Return
0 %
3 Year Return
+ 412.5 %
5 Year Return
-70.71 %

Crescent Biopharma, Inc. Stock Fundamentals & Key Indicators

Check Crescent Biopharma, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$495.8M

EPS (TTM)

-2.62

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-160.75%

Crescent Biopharma, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Crescent Biopharma, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Crescent Biopharma, Inc. image
Crescent Biopharma, Inc.
NA$495.8M-70.71%NA0.00%NA
Revolution Medicines Inc image
Revolution Medicines Inc
BUY$32.2B410.63%NA0.00%NA
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$39.1B108.54%73.5112.55%NA
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$108.7B110.42%25.4535.51%NA
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$64.9B22.83%15.1129.65%0.59%

Stock Returns calculator for Crescent Biopharma, Inc. Stock including INR - Dollar returns

The Crescent Biopharma, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Crescent Biopharma, Inc. investment value today

Current value as on today

₹5,69,437

Returns

₹4,69,437

(+469.44%)

Returns from Crescent Biopharma, Inc. Stock

₹3,95,000 (+395%)

Dollar Impact

₹74,437 (+74.44%)

Indian Investors' Interest in Crescent Biopharma, Inc. Stock

Search interest for Crescent Biopharma, Inc. Stock has increased by 11% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:11% versus previous 30 day period

Crescent Biopharma, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
-
-
-
30
10
1
Gross Profit
0
0
-
0
28
10
1
Operating Income
-9
-17
-14
-21
-25
-91
-24
EBITDA
-9
-17
-14
-20
-24
-90
-23
Interest Expense
-
0
1
1
-
3
-
Depreciation
-
-
-
0
0
0
0
Income Before Tax
-9
-17
-15
-21
-24
-90
-23
Income Tax Expense
-
-
-
-
-
2
-
Net Income
-9
-17
-15
-21
-24
-92
-23
Net Profit Margin
-90786.40%
0.00%
0.00%
0.00%
-80.51%
-852.06%
-2240.90%

Crescent Biopharma, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2025
Total Revenue
0
10
1
0
0
10
Gross Profit
0
10
1
0
0
10
Operating Income
-31
-51
-63
-47
-39
-152
EBITDA
-31
-51
-63
-47
-39
-149
Interest Expense
-
-
-
-
-
2
Depreciation
-
-
-
-
-
0
Income Before Tax
-31
-51
-63
-46
-36
-151
Income Tax Expense
-
-
-
-
-
2
Net Income
-31
-51
-63
-46
-36
-153
Net Profit Margin
-171945.07%
-502.09%
-5468.98%
-62251.74%
-368994.20%
-1419.61%

Crescent Biopharma, Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-10
-10
-2
-37
-2
-21
-24
-92
-23
Operating Cash Flow
-10
-8
19
-6
-5
-22
-17
-26
-8
Investing Cash Flow
0
0
0
0
-
0
0
-72
-8
Financing Cash Flow
0
0
0
41
-1
145
-1
178
-6
Change in Cash
-10
-8
-22
34
-5
147
-19
79
-24

Crescent Biopharma, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-33
-48
-57
-51
-63
-46
-36
-37
-149
Operating Cash Flow
-29
-43
-51
-39
-57
-46
-34
-31
-71
Investing Cash Flow
0
0
0
0
0
0
0
0
-72
Financing Cash Flow
113
129
0
18
10
4
28
0
322
Change in Cash
83
85
-51
-21
-46
-42
-6
-31
178

Global Institutional Holdings in Crescent Biopharma, Inc.

Funds
Holdings
FMR Inc
14.99%
Raymond James & Associates
0%
Balyasny Asset Management LLC
5.48%
Cutler Group LP
0%
Logos Global Management LP
1.75%
See all

Insights on Crescent Biopharma, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, CBIO has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, CBIO stock has moved up by 9190.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 503.0% return, outperforming this stock by 90.5%

About Crescent Biopharma, Inc.

Crescent Biopharma, Inc., a biotechnology company, researches and develops cancer therapy candidates in the United States. Its pipeline includes CR-001, which is in Phase 3 clinical trial, a proprietary anti-PD-1/anti-VEGF bispecific antibody to treat solid tumors; and CR-002, and CR-003. The company has a strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. for the development and commercialization of oncology therapeutics. The company was formerly known as GlycoMimetics, Inc. The company was founded in 2024 and is headquartered in Waltham, Massachusetts.
OrganisationCrescent Biopharma, Inc.
Headquarters300 Fifth Avenue, Waltham, MA, United States, 02451
IndustryBiotechnology
CEOMr. Joshua T. Brumm
E-voting on sharesClick here to vote

Key Management of Crescent Biopharma, Inc.

Name

Title

Ms. Barbara Bispham Hale J.D.

General Counsel & Corporate Secretary

Dr. Wenjie Cheng Ph.D.

Senior Vice President of Technical Operations

Dr. Jonathan McNeill M.D.

President & COO

Dr. Ellie Im M.D.

Chief Medical Officer

Mr. Richard William Scalzo M.B.A.

Chief Financial Officer

Mr. Ryan Lynch

Senior VP of Finance, Treasurer & Chief Accounting Officer

Dr. Jan Pinkas Ph.D.

Chief Scientific Officer

Ms. Amy Reilly

Chief Communications Officer

Mr. Christopher Doughty

Chief Business Officer

Mr. Joshua T. Brumm

CEO & Director

FAQs

What is Crescent Biopharma, Inc. share price today?

Crescent Biopharma, Inc. share price today is $17.82 as on . Crescent Biopharma, Inc. share today touched a day high of $19 and a low of $17.71.

What is the 52 week high and 52 week low for Crescent Biopharma, Inc. share?

Crescent Biopharma, Inc. share touched a 52 week high of $27.41 on and a 52 week low of $8.72 on . Crescent Biopharma, Inc. stock price today i.e. is trending at $17.82,which is 34.99% down from its 52 week high and 104.36% up from its 52 week low.

What is Crescent Biopharma, Inc.'s market capitalisation today?

Crescent Biopharma, Inc. market capitalisation is $0.00T as on .

How to invest in Crescent Biopharma, Inc. Stock (CBIO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Crescent Biopharma, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Crescent Biopharma, Inc. Shares that will get you 0.0842 shares as per Crescent Biopharma, Inc. share price of $17.82 per share as on June 5, 2026 at 8:06 pm IST.

What is the minimum amount required to buy Crescent Biopharma, Inc. Stock (CBIO) from India?

Indian investors can start investing in Crescent Biopharma, Inc. (CBIO) shares with as little as ₹94.935 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.35 in Crescent Biopharma, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Crescent Biopharma, Inc. share’s latest price of $17.82 as on June 5, 2026 at 8:06 pm IST, you will get 0.5612 shares of Crescent Biopharma, Inc.. Learn more about fractional shares .

What are the returns that Crescent Biopharma, Inc. has given to Indian investors in the last 5 years?

Crescent Biopharma, Inc. stock has given -70.71% share price returns and 30.84% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?